Antibody-drug conjugates?or?ADCs?are a class of?biopharmaceutical?drugs designed as a?targeted therapy?for treating cancer.[1]?Unlike?chemotherapy, ADCs are intended to target and kill tumor cells while sparing healthy cells. As of 2019, some 56 pharmaceutical companies were developing ADCs.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Antibody-drug Conjugate industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Adcetris
Kadcyla
Market Segment by Product Application
Breast Cancer
Lymphoma
Finally, the report provides detailed profile and data information analysis of leading company.
ImmunoGen
Seattle Genetics
Roche
Takeda
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Antibody-drug Conjugate consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Antibody-drug Conjugate market by identifying its various subsegments.
3.Focuses on the key global Antibody-drug Conjugate manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Antibody-drug Conjugate with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Antibody-drug Conjugate submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Antibody-drug Conjugate Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Antibody-drug Conjugate Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Antibody-drug Conjugate Segment by Type
2.1.1 Adcetris
2.1.2 Kadcyla
2.2 Market Analysis by Application
2.2.1 Breast Cancer
2.2.2 Lymphoma
2.3 Global Antibody-drug Conjugate Market Comparison by Regions (2017-2027)
2.3.1 Global Antibody-drug Conjugate Market Size (2017-2027)
2.3.2 North America Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.3 Europe Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.4 China Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.5 Japan Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.6 Southeast Asia Antibody-drug Conjugate Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Antibody-drug Conjugate Industry Impact
2.5.1 Antibody-drug Conjugate Business Impact Assessment - Covid-19
2.5.2 Market Trends and Antibody-drug Conjugate Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Antibody-drug Conjugate Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Antibody-drug Conjugate Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Antibody-drug Conjugate Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Antibody-drug Conjugate Manufacturer Market Share
3.5 Top 10 Antibody-drug Conjugate Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
3.7 Key Manufacturers Antibody-drug Conjugate Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Antibody-drug Conjugate Industry Key Manufacturers
4.1 ImmunoGen
4.1.1 Compan Detail
4.1.2 ImmunoGen Antibody-drug Conjugate Product Introduction, Application and Specification
4.1.3 ImmunoGen 136 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 ImmunoGen News
4.2 Seattle Genetics
4.2.1 Compan Detail
4.2.2 Seattle Genetics Antibody-drug Conjugate Product Introduction, Application and Specification
4.2.3 Seattle Genetics Antibody-drug Conjugate Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 ImmunoGen News
4.3 Roche
4.3.1 Compan Detail
4.3.2 Roche Antibody-drug Conjugate Product Introduction, Application and Specification
4.3.3 Roche Antibody-drug Conjugate Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Roche News
4.4 Takeda
4.4.1 Compan Detail
4.4.2 Takeda Antibody-drug Conjugate Product Introduction, Application and Specification
4.4.3 Takeda Antibody-drug Conjugate Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Takeda News
5 Global Antibody-drug Conjugate Market Segment by Big Type
5.1 Global Antibody-drug Conjugate Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Antibody-drug Conjugate Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Antibody-drug Conjugate Revenue and Market Share by Big Type (2017-2022)
5.2 Adcetris Sales Growth Rate and Price
5.2.1 Global Adcetris Sales Growth Rate (2017-2022)
5.2.2 Global Adcetris Price (2017-2022)
5.3 Kadcyla Sales Growth Rate and Price
5.3.1 Global Kadcyla Sales Growth Rate (2017-2022)
5.3.2 Global Kadcyla Price (2017-2022)
6 Global Antibody-drug Conjugate Market Segment by Big Application
6.1 Global Antibody-drug Conjugate Sales Market Share by Big Application (2017-2022)
6.2 Breast Cancer Sales Growth Rate (2017-2022)
6.3 Lymphoma Sales Growth Rate (2017-2022)
7 Global Antibody-drug Conjugate Forecast
7.1 Global Antibody-drug Conjugate Revenue, Sales and Growth Rate (2022-2027)
7.2 Antibody-drug Conjugate Market Forecast by Regions (2022-2027)
7.2.1 North America Antibody-drug Conjugate Market Forecast (2022-2027)
7.2.2 Europe Antibody-drug Conjugate Market Forecast (2022-2027)
7.2.3 China Antibody-drug Conjugate Market Forecast (2022-2027)
7.2.4 Japan Antibody-drug Conjugate Market Forecast (2022-2027)
7.2.5 Southeast Asia Antibody-drug Conjugate Market Forecast (2022-2027)
7.2.6 Other Regions Antibody-drug Conjugate Market Forecast (2022-2027)
7.3 Antibody-drug Conjugate Market Forecast by Type (2022-2027)
7.3.1 Global Antibody-drug Conjugate Sales Forecast by Type (2022-2027)
7.3.2 Global Antibody-drug Conjugate Market Share Forecast by Type (2022-2027)
7.4 Antibody-drug Conjugate Market Forecast by Application (2022-2027)
7.4.1 Global Antibody-drug Conjugate Sales Forecast by Application (2022-2027)
7.4.2 Global Antibody-drug Conjugate Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Antibody-drug Conjugate Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Antibody-drug Conjugate Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Antibody-drug Conjugate
Figure Market Concentration Ratio and Market Maturity Analysis of Antibody-drug Conjugate
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Antibody-drug Conjugate Market Size by Big Type
Figure Global Market Share of Antibody-drug Conjugate by Big Type in 2021
Figure Adcetris Picture (2017-2022)
Global Antibody-drug Conjugate Market Size by Big Application
Table Global Antibody-drug Conjugate Market Size by Application
Figure Global Antibody-drug Conjugate Market Share by Big Application in 2021
Figure Breast Cancer Picture
Figure Lymphoma Picture
Table Global Antibody-drug Conjugate Comparison by Regions (M USD) ?2017-2027?
Figure Global Antibody-drug Conjugate Market Size (Million US$) (2017-2027)
Figure North America Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure China Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Antibody-drug Conjugate Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Antibody-drug Conjugate Sales by Manufacturer (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Manufacturer in 2021
Table Global Antibody-drug Conjugate Revenue by Manufacturer (2017-2022)
Figure Global Antibody-drug Conjugate Revenue Market Share by Manufacturer in 2021
Table Global Antibody-drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Antibody-drug Conjugate Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Antibody-drug Conjugate Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
Table Key Manufacturers Antibody-drug Conjugate Product Type
Table Mergers & Acquisitions Planning
Table ImmunoGen Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of ImmunoGen
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Seattle Genetics Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of Seattle Genetics
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Seattle Genetics Recent Development
Table Roche Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of Roche
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Takeda Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of Takeda
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Takeda Main Business
Table Takeda Recent Development
Table Takeda Main Business
Table Takeda Recent Development
Figure Global Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Global Antibody-drug Conjugate Revenue and Growth Rate (2017-2022)
Table Global Antibody-drug Conjugate Sales by Regions (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Regions in 2021
Table Global Antibody-drug Conjugate Revenue by Regions (2017-2022)
Figure Global Antibody-drug Conjugate Revenue Market Share by Regions in 2021
Figure North America Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Europe Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure China Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Japan Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Southeast Asia Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Other Regions Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Table Global Antibody-drug Conjugate Sales by Big Type (2017-2022)
Table Global Antibody-drug Conjugate Sales Market Share by Big Type (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Big Type in 2019
Table Global Antibody-drug Conjugate Revenue by Big Type (2017-2022)
Table Global Antibody-drug Conjugate Revenue Market Share by Big Type (2017-2022)
Table Global Antibody-drug Conjugate Revenue Market Share by Big Type in 2019
Figure Global Adcetris Sales Growth Rate (2017-2022)
Figure Global Adcetris Price (2017-2022)
Figure Global Kadcyla Sales Growth Rate (2017-2022)
Table Global Antibody-drug Conjugate Sales by Big Application (2017-2022)
Table Global Antibody-drug Conjugate Sales Market Share by Big Application (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Big Application in 2019
Figure Global Breast Cancer Sales Growth Rate (2017-2022)
Figure Global Lymphoma Sales Growth Rate (2017-2022)
Figure Global Antibody-drug Conjugate Sales and Growth Rate (2022-2027)
Figure Global Antibody-drug Conjugate Revenue and Growth Rate (2022-2027)
Table Global Antibody-drug Conjugate Sales Forecast by Regions (2022-2027)
Table Global Antibody-drug Conjugate Market Share Forecast by Regions (2022-2027)
Figure North America Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure Europe Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure China Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure Japan Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure Southeast Asia Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure Other Regions Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Table Global Antibody-drug Conjugate Sales Forecast by Type (2022-2027)
Table Global Antibody-drug Conjugate Market Share Forecast by Type (2022-2027)
Table Global Antibody-drug Conjugate Sales Forecast by Application (2022-2027)
Table Global Antibody-drug Conjugate Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody-drug Conjugate
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Antibody-drug Conjugate Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Antibody-drug Conjugate Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Antibody-drug Conjugate Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Antibody-drug Conjugate Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Antibody-drug Conjugate Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Antibody-drug Conjugate Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Antibody-drug Conjugate Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Antibody-drug Conjugate Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
ImmunoGen
Seattle Genetics
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)